An automated system of color retinal image analysis represents a potential new screening method for exudative diabetic retinopathy.

Doxazosin, an alpha-adrenergic blocking agent, appears to have a beneficial effect on adipose endocrine activity and may improve insulin resistance and dyslipidaemia in obese hypertensive patients.

Patients with diabetes and a certain genetic subtype of diabetes can be shown to be very sensitive for sulfonylurea.

Statins and other lipid-lowering drugs are associated with reduction in the risk of breast cancer, according to the results of a multicenter, prospective cohort study.

A laparoscopically inserted weight loss device called the implantable gastric stimulator (IGS) caused weight loss in 80% of patients, according to new research.

Anemia significantly affects the quality of life in people with diabetes, but it often goes unrecognized and undetected and, therefore, untreated in many patients, reports a pan-European study.

Thiazolidinediones can cause or exacerbate heart failure and pulmonary oedema, and should be avoided in patients with left ventricular dysfunction or chronic renal insufficiency, according to the conclusion of a new report.

Significant reductions in life expectancy were also shown and the researchers estimate that if an individual “is diagnosed at age 40 years, men will lose 11.6 life-years…and women will lose 14.3 life-years.”

Cardiovascular complications are the leading cause of morbidity and mortality for people with diabetes; as many as 80% of patients with type 2 diabetes die from cardiovascular events.

An elevated glycemic load is an independent risk factor for future coronary events in patients with coronary heart disease (CHD), results of the Long-term Intervention with Pravastatin in Ischaemic Disease(LIPID) study. Reported at the 13th International Symposium on Atherosclerosis.